Investors – Microbiotica

British Patient Capital

British Patient Capital is the trading name of British Patient Capital Limited, a wholly-owned commercial subsidiary of British Business Bank plc, the UK government’s economic development bank. It forms part of the British Business Bank’s plc’s commercial arm.

Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large scale businesses. Launched in June 2018, British Patient Capital has £2.5 billion to invest over 10 years in venture and venture growth capital to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. Find out more at britishpatientcapital.co.uk.

British Business Bank plc and its subsidiary entities are not banking institutions and do not operate as such. They are not authorised or regulated by the Prudential Regulation Authority (PRA) or the Financial Conduct Authority (FCA). A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc website.

British Patient Capital makes commitments and invests on its own behalf and on behalf of third-party investors whose investments British Patient Capital manages.

Cambridge Innovation Capital

Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, it has unparalleled access to investment opportunities in the ecosystem. Since its inception in 2013, it has raised £275 million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.

Flerie Invest

Flerie Invest is a Swedish biotech and pharma investor managing a portfolio of more than 20 companies in Sweden, the UK, the US, the Netherlands, Iceland, and Israel. The portfolio companies are engaged in a wide range of areas including immuno-oncology, metabolic diseases and biologics development and manufacturing. The present investment focus is on drug development and tools for drug development. The company was founded in 2010 by Thomas Eldered, who also co-founded and built Recipharm to be one of the top five CDMOs globally. Flerie Invest is based in Stockholm.

IP Group

IP Group was set up with a mission to evolve great ideas, mainly from partner universities, into world-changing businesses. It achieves this by systematically helping to create, build and support outstanding intellectual property-based companies. The Group pioneered the concept of the long-term partnership model with UK universities and has spent many years honing a unique approach to building businesses and providing support along the journey from “cradle to maturity”. It has replicated this approach with a select group of US research institutions and, in 2017, the Group announced it was expanding into Australasia.

Seventure Partners Health for Life Capital

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment through its Health for Life Capital™ fund. The fund focuses on the microbiome, and health, nutrition and digital/connected health sectors, and is backed by strategic investments from organizations including Danone, Novartis, Lesaffre, Tornier, Unigrains and Bel. Health for Life Capital™ supports innovative high-growth entrepreneurial ventures across Europe, Israel, North America and Asia.

Tencent

Tencent uses technology to enrich the lives of Internet users.

Its communication and social services, Weixin and QQ, connect users with each other and with digital content and services, both online and offline, making their lives more convenient. Its targeted advertising service helps advertisers reach out to hundreds of millions of consumers in China. Its FinTech and business services support our partners’ business growth and assist their digital upgrade.

Tencent invests heavily in talent and technological innovation, actively promoting the development of the Internet industry. Tencent was founded in Shenzhen, China, in 1998. Shares of Tencent (00700.HK) are listed on the Main Board of the Stock Exchange of Hong Kong.